HIGHLIGHTS
- who: Keren Masha Rabinowitz and collaborators from the Division of Gastroenterology, Rabin Medical Center, Petah Tikva, IsraelDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University have published the Article: Anti-TNF Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases, in the Journal: Vaccines 2022, 10, 1186. of 19/06/2022
- what: The authors aimed to continue the prospective assessment of long-term immune_responses in patients with IBD stratified according to therapy, focusing on the differential response one and six months post BNT162b2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.